HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Autophagy induced by conventional chemotherapy mediates tumor cell sensitivity to immunotherapy.

Abstract
Autophagy attenuates the efficacy of conventional chemotherapy but its effects on immunotherapy have been little studied. Here, we report that chemotherapy renders tumor cells more susceptible to lysis by CTL in vivo. Moreover, bystander tumor cells that did not express antigen were killed by CTL. This effect was mediated by transient but dramatic upregulation of the mannose-6-phosphate receptor (MPR) on the tumor cell surface. Antitumor effects of combined treatment related to the kinetics of MPR upregulation and abrogation of this event abolished the combined effect of immunotherapy and chemotherapy. MPR accumulation on the tumor cell surface during chemotherapy was observed in different mouse tumor models and in patients with multiple myeloma. Notably, this effect was the result of redistribution of the receptor caused by chemotherapy-inducible autophagy. Together, our findings reveal one molecular mechanism through which the antitumor effects of conventional cancer chemotherapy and immunotherapy are realized.
AuthorsRupal Ramakrishnan, Chun Huang, Hyun-Il Cho, Mark Lloyd, Joseph Johnson, Xiubao Ren, Soner Altiok, Daniel Sullivan, Jeffrey Weber, Esteban Celis, Dmitry I Gabrilovich
JournalCancer research (Cancer Res) Vol. 72 Issue 21 Pg. 5483-93 (Nov 01 2012) ISSN: 1538-7445 [Electronic] United States
PMID22942258 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright2012 AACR.
Chemical References
  • Antineoplastic Agents
  • Receptor, IGF Type 2
Topics
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Autophagy (drug effects)
  • Blotting, Western
  • Combined Modality Therapy
  • Cytotoxicity, Immunologic (physiology)
  • Drug Therapy
  • Female
  • Humans
  • Immunohistochemistry
  • Immunotherapy (methods)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Microscopy, Confocal
  • Neoplasms (immunology, metabolism, therapy)
  • Real-Time Polymerase Chain Reaction
  • Receptor, IGF Type 2 (biosynthesis)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transfection
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: